Saving changes...

Done

Error

Clinical & Managed Care Considerations of Non-Hodgkin's Lymphoma for the Specialty Pharmacist & the Collaborative Healthcare Team

Clinical & Managed Care Considerations of Non-Hodgkin's Lymphoma for the Specialty Pharmacist & the Collaborative Healthcare Team

Clinical & Managed Care Considerations of Non-Hodgkin's Lymphoma for the Specialty Pharmacist & the Collaborative Healthcare Team

Ashley Glode, PharmD, BCOP
Ashley Glode, PharmD, BCOP
on behalf of Specialty Pharma Education Center

$ 12.99 $ 12.99 $ 12.99

$ 12.99 $ 12.99 $ 12.99

$ 12.99 $ 12.99 $ 12.99
$ 12.99 $ 12.99 $ 12.99
Normal Price: $ 12.99 $ 12.99

Review:

Launch date: 06 Jul 2016

Expiry Date: 01 Apr 2018

Last updated: 26 Sep 2017

Reference: 163590

$ 12.99 $ 12.99 $ 12.99
$ 12.99 $ 12.99 $ 12.99
Clinical & Managed Care Considerations of Non-Hodgkin's Lymphoma for the Specialty Pharmacist & the Collaborative Healthcare Team
Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

A comprehensive course on Clinical & Managed Care Considerations of Non-Hodgkin's Lymphoma for the Specialty Pharmacist & the Collaborative Healthcare Team.

Faculty Disclosures:
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Objectives

After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Nurses, and Infusion Nurses along with other healthcare practitioner participants will be able to:
1. Understand the epidemiology and risk factors for Non-Hodgkin's Lymphoma (NHL)
2. Learn about the pathobiology of the types of NHL
3. Gain an understanding of staging of NHL and how treatment varies by stage
4. Review the recommended treatments for the types of NHL based on pathobiology
5. Review the treatments for relapsed/refractory disease
6. Review the pipeline for NHL and future investigational therapies
7. Review the biggest barriers to adherence and persistence in NHL
8. Understand the cost implications of the various therapeutic approaches to the treatment of NHL
9. Learn how to manage and provide support to the payer, provider, and patient for NHL
Ashley Glode, PharmD, BCOP

Author Information Play Video Bio

Ashley Glode, PharmD, BCOP
on behalf of Specialty Pharma Education Center

Ashley Glode, PharmD, BCOP
Clinical Oncology Pharmacy Specialist
PGY2 Oncology Residency Program Director

Medical University of South Carolina/South Carolina College of Pharmacy

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 2.00 Hours -
    Reference number: 0535-0000-15-004-H01-P

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error